Jump to main content or area navigation.

Contact Us

Extramural Research

Grantee Research Project Results

Grantee Research Project Results

Mechanism of Retinoic Acid-Induced Neural Tube Defects-The Role of the Retinoic Acid Receptors RAR-Beta and RAR-Gamma

EPA Grant Number: U915462
Title: Mechanism of Retinoic Acid-Induced Neural Tube Defects-The Role of the Retinoic Acid Receptors RAR-Beta and RAR-Gamma
Investigators: Mao, Gloria
Institution: University of California - Los Angeles
EPA Project Officer: Manty, Dale
Project Period: September 1, 1998 through September 1, 2001
Project Amount: $39,178
RFA: STAR Graduate Fellowships (1998)
Research Category: Fellowship - Toxicology , Health Effects , Academic Fellowships

Description:

Objective:

The objective of this research project is to determine whether: (1) Retinoic Acid Receptor (RAR)-beta or RAR-gamma isoforms are specifically expressed during neurulation; (2) the switch in expression from RAR-gamma in the open neural tube to RAR-beta in the closed neural tube is essential for posterior neural tube closure; and (3) retinoic acid or genetic mutations, which induce neural tube defects, disrupt RAR-beta or RAR-gamma expression. Excess retinoic acid, a metabolite of vitamin A (retinol), causes developmental malformations including the neural tube closure defect spina bifida in the mouse. The effects of retinoic acid are mediated by RARs and Retinoid X Receptors (RXRs) (receptors that act as regulatory gene transcription factors). RAR has three subtypes: alpha, beta, and gamma; additionally, each subtype has several isoforms. Neural tube closure in the posterior neural tube is associated with a change in expression from RAR-gamma in the open neural tube to RAR-beta after closure. Retinoic acid can regulate the expression of RAR-beta and RAR-gamma, which poses the question of whether retinoic acid disrupts neural tube closure by perturbing the normal expression patterns of RAR-beta and RAR-gamma.

Approach:

RAR-beta and RAR-gamma isoform expression levels have been quantitated by ribonuclease protection assays, and their expression patterns have been determined by whole-mount in situ hybridization in mouse embryos during neurulation. The regulation of RAR-beta and RAR-gamma expression has been examined by similar methods in embryos that have neural tube defects induced by retinoic acid. This research project has shown that in retinoic acid-treated embryos, RAR-gamma downregulation in the closing neural tube and RAR-beta upregulation in the closed neural tube occurred normally, and were not disrupted by retinoic acid. Additionally, the transition from RAR-gamma to RAR-beta expression has been examined in Splotch mutant mice that develop posterior neural tube defects. Identifying genes involved in neural tube closure will be accomplished by using cDNA expression array techniques to determine differences in gene expression before and after neural tube closure or after retinoic acid treatment.

Supplemental Keywords:

fellowship, neural tube defects, Retinoic Acid Receptors, RARs, Retinoid X Receptors, RXRs, spina bifida, developmental malformations., RFA, Health, Scientific Discipline, Genetics, Chemistry, Risk Assessments, Disease & Cumulative Effects, Biochemistry, Children's Health, Molecular Biology/Genetics, Biology, neural tube defects, embryos, neurodevelopment, neurodevelopmental, gene expression, retinoic acid receptors

Top of Page

The perspectives, information and conclusions conveyed in research project abstracts, progress reports, final reports, journal abstracts and journal publications convey the viewpoints of the principal investigator and may not represent the views and policies of ORD and EPA. Conclusions drawn by the principal investigators have not been reviewed by the Agency.

Jump to main content.